ValuEngine upgraded shares of MAXIMUS (NYSE:MMS) from a hold rating to a buy rating in a research note issued to investors on Friday morning.
A number of other analysts have also issued reports on the company. Canaccord Genuity lifted their target price on MAXIMUS from $64.00 to $67.00 and gave the stock a hold rating in a research report on Wednesday, October 10th. Zacks Investment Research raised MAXIMUS from a sell rating to a hold rating in a research report on Tuesday, August 14th. Two research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. The company currently has an average rating of Buy and a consensus target price of $72.00.
Shares of NYSE MMS opened at $71.12 on Friday. MAXIMUS has a 1 year low of $60.00 and a 1 year high of $72.71. The stock has a market cap of $4.47 billion, a PE ratio of 20.92, a price-to-earnings-growth ratio of 1.91 and a beta of 0.97.
The firm also recently announced a quarterly dividend, which was paid on Friday, November 30th. Stockholders of record on Thursday, November 15th were given a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a dividend yield of 1.41%. This is a positive change from MAXIMUS’s previous quarterly dividend of $0.05. The ex-dividend date was Wednesday, November 14th. MAXIMUS’s payout ratio is presently 29.41%.
In related news, Director Russell A. Beliveau sold 1,000 shares of the business’s stock in a transaction dated Monday, October 1st. The stock was sold at an average price of $63.86, for a total value of $63,860.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Vice Chairman Richard A. Montoni sold 44,002 shares of the business’s stock in a transaction dated Thursday, September 20th. The shares were sold at an average price of $64.99, for a total value of $2,859,689.98. Following the completion of the sale, the insider now directly owns 493,476 shares of the company’s stock, valued at $32,071,005.24. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 95,329 shares of company stock worth $6,295,626. Corporate insiders own 3.10% of the company’s stock.
Institutional investors have recently made changes to their positions in the stock. Bruderman Asset Management LLC bought a new stake in MAXIMUS in the second quarter valued at about $119,000. Fort L.P. bought a new stake in MAXIMUS in the second quarter valued at about $120,000. Violich Capital Management Inc. bought a new stake in MAXIMUS in the second quarter valued at about $204,000. Advisors Asset Management Inc. increased its holdings in MAXIMUS by 132.3% in the second quarter. Advisors Asset Management Inc. now owns 3,807 shares of the health services provider’s stock valued at $461,000 after buying an additional 2,168 shares during the last quarter. Finally, Engineers Gate Manager LP bought a new stake in MAXIMUS in the third quarter valued at about $254,000. 93.53% of the stock is owned by hedge funds and other institutional investors.
MAXIMUS Company Profile
MAXIMUS, Inc provides business process services (BPS) to government health and human services programs in the United States, the United Kingdom, Australia, Canada, Singapore, and Saudi Arabia. The company's Health Services segment offers various BPS, appeals, and assessments, as well as related consulting services for state, provincial, and national government programs comprising Medicaid, Children's Health Insurance Program, the Affordable Care Act, Health Insurance British Columbia, the Health Assessment Advisory Service, and Preadmission Screening and Resident Reviews.
Recommended Story: How to Invest in a Bull Market
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for MAXIMUS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MAXIMUS and related companies with MarketBeat.com's FREE daily email newsletter.